Published in J Clin Oncol on March 15, 2001
Oral cancer treatment: developments in chemotherapy and beyond. Br J Cancer (2002) 1.44
Sorafenib in platinum-treated patients with extensive stage small cell lung cancer: a Southwest Oncology Group (SWOG 0435) phase II trial. J Thorac Oncol (2010) 1.29
Management of small-cell lung cancer: incremental changes but hope for the future. Oncology (Williston Park) (2008) 1.20
A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer. Lung Cancer (2011) 1.10
Treatment options for small cell lung cancer - do we have more choice? Br J Cancer (2010) 1.07
In vivo characterization of a polymeric nanoparticle platform with potential oral drug delivery capabilities. Mol Cancer Ther (2008) 0.99
Topotecan for Relapsed Small-cell Lung Cancer: Systematic Review and Meta-Analysis of 1347 Patients. Sci Rep (2015) 0.95
Polymeric nanoparticle technologies for oral drug delivery. Clin Gastroenterol Hepatol (2014) 0.92
Topotecan: An evolving option in the treatment of relapsed small cell lung cancer. Ther Clin Risk Manag (2007) 0.85
Factors affecting pharmacokinetic variability of oral topotecan: a population analysis. Br J Cancer (2004) 0.84
Systematic Review of topotecan (Hycamtin) in relapsed small cell lung cancer. BMC Cancer (2010) 0.83
Ex vivo analysis of topotecan: advancing the application of laboratory-based clinical therapeutics. Br J Cancer (2003) 0.81
Topotecan in the treatment of relapsed small cell lung cancer. Onco Targets Ther (2008) 0.81
Polymeric nanoparticle drug delivery technologies for oral delivery applications. Expert Opin Drug Deliv (2015) 0.80
Topotecan inhibits cancer cell migration by down-regulation of chemokine CC motif receptor 7 and matrix metalloproteinases. Acta Pharmacol Sin (2009) 0.78
VAC chemotherapy with valproic acid for refractory/relapsing small cell lung cancer: a phase II study. ERJ Open Res (2015) 0.77
Pharmacodynamics and pharmacokinetics of oral topotecan in patients with advanced solid tumours and impaired renal function. Br J Clin Pharmacol (2015) 0.77
Phase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumours. Br J Cancer (2015) 0.76
Synergistic combination of DT-13 and topotecan inhibits human gastric cancer via myosin IIA-induced endocytosis of EGF receptor in vitro and in vivo. Oncotarget (2016) 0.76
Phase II study of bendamustine in relapsed chemotherapy sensitive or resistant small-cell lung cancer. J Thorac Oncol (2014) 0.76
Chemotherapy for small cell lung cancer: a comprehensive review. Oncol Rev (2012) 0.75
Efficacy of topotecan in pretreated metastatic poorly differentiated extrapulmonary neuroendocrine carcinoma. Cancer Med (2016) 0.75
Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events. Cancers (Basel) (2017) 0.75
[Small cell lung cancer]. Wien Klin Wochenschr (2007) 0.75
Extensive genome-wide linkage disequilibrium in cattle. Genome Res (2000) 8.31
RENAL PLASMA FLOW AND SODIUM REABSORPTION AND EXCRETION IN CONGESTIVE HEART FAILURE. J Clin Invest (1948) 4.52
Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types. J Clin Oncol (2002) 4.25
Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer. J Clin Oncol (1999) 3.48
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst (1995) 3.25
Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences. EMBO J (2001) 3.21
The role of tutoring in problem solving. J Child Psychol Psychiatry (1976) 2.97
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol (2000) 2.73
Nasal tube switch: converting from a nasal to an oral endotracheal tube without extubation. J Oral Maxillofac Surg (1994) 2.69
Latrine ownership as a protective factor in inflammatory trachoma in Egypt. Br J Ophthalmol (1991) 2.67
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients. J Clin Oncol (1994) 2.66
Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J Clin Oncol (2000) 2.48
Hyperglycaemia as a predictor of outcome during non-invasive ventilation in decompensated COPD. Thorax (2009) 2.31
Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest (1998) 2.27
Ranitidine 150 mg twice daily vs 300 mg nightly in treatment of duodenal ulcers. Lancet (1984) 2.25
Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab (1994) 2.23
Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. J Clin Oncol (1999) 2.19
Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification. Curr Biol (1999) 2.17
An imprinted QTL with major effect on muscle mass and fat deposition maps to the IGF2 locus in pigs. Nat Genet (1999) 2.16
Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial. Ann Oncol (2002) 2.14
Cytotoxic and anticancer activities of isatin and its derivatives: a comprehensive review from 2000-2008. Anticancer Agents Med Chem (2009) 2.09
Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer (1993) 2.08
Substitution of a nursing-led inpatient unit for acute services: randomized controlled trial of outcomes and cost of nursing-led intermediate care. Age Ageing (2001) 2.07
Drug eluting stents. BMJ (2006) 2.02
Connected populations for detecting quantitative trait loci and testing for epistasis: an application in maize. Theor Appl Genet (2006) 1.98
Genetic and nongenetic bases for the L-shaped distribution of quantitative trait loci effects. Genetics (2001) 1.92
The relative incidence of anterior cruciate ligament injury in men and women at the United States Naval Academy. Am J Sports Med (2000) 1.83
Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study. J Natl Cancer Inst (2001) 1.82
How do teenagers and primary healthcare providers view each other? An overview of key themes. Br J Gen Pract (2001) 1.71
Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer. N Engl J Med (1993) 1.69
Selective arterial drug infusions in the treatment of acute gastrointestinal bleeding. A preliminary report. Gastroenterology (1970) 1.66
THE EFFECT OF SPINAL ANESTHESIA ON THE RENAL ISCHEMIA IN CONGESTIVE HEART FAILURE. J Clin Invest (1948) 1.64
Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9. Blood (2001) 1.64
Randomized phase II study of temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanoma. J Clin Oncol (2003) 1.62
A randomised trial of oral versus intravenous topotecan in patients with relapsed epithelial ovarian cancer. Eur J Cancer (2002) 1.62
Chronic neurodegenerative disease associated with HTLV-II infection. Lancet (1992) 1.58
Muscle testing response to provocative vertebral challenge and spinal manipulation: a randomized controlled trial of construct validity. J Manipulative Physiol Ther (1994) 1.57
Effects of adrenaline and noradrenaline on coronary blood flow before and after beta-adrenergic blockade. Br J Pharmacol Chemother (1966) 1.54
A systematic review of the clinical relevance of repetitive transcranial magnetic stimulation. Acta Psychiatr Scand (2014) 1.53
Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice. J Immunol (2000) 1.52
Delayed sleep phase syndrome. A chronobiological disorder with sleep-onset insomnia. Arch Gen Psychiatry (1981) 1.51
Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study. Br J Cancer (2009) 1.50
REM sleep episodes during the Multple Sleep Latency Test in narcoleptic patients. Electroencephalogr Clin Neurophysiol (1979) 1.49
A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents. Health Technol Assess (2006) 1.49
Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapy. Lung Cancer (2000) 1.48
Expression of the uptake drug transporter hOCT1 is an important clinical determinant of the response to imatinib in chronic myeloid leukemia. Clin Pharmacol Ther (2007) 1.47
Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer. Br J Cancer (2004) 1.45
Role of magnetic resonance imaging in the diagnosis and single-stage surgical resection of invasive lobular carcinoma of the breast. Br J Surg (2002) 1.44
Escherichia coli and the human gut: some ecological considerations. J Appl Bacteriol (1981) 1.44
An electromagnetic catheter-flowmeter. Circ Res (1967) 1.42
Management of frozen shoulder: a systematic review and cost-effectiveness analysis. Health Technol Assess (2012) 1.42
Biomarker method validation in anticancer drug development. Br J Pharmacol (2007) 1.41
The ankle-link antigen: an epitope sensitive to calcium chelation associated with the hair-cell surface and the calycal processes of photoreceptors. J Neurosci (1999) 1.40
Transport of animals. Vet Rec (1995) 1.39
Screening for gestational diabetes. Med J Aust (1992) 1.39
[Recommendations on the therapy of bronchial carcinoma]. Pneumologie (2002) 1.39
The effects of ventilatory pattern on hyperinflation, airway pressures, and circulation in mechanical ventilation of patients with severe air-flow obstruction. Am Rev Respir Dis (1987) 1.38
Hydrophobic surfactant-associated protein in whole lung surfactant and its importance for biophysical activity in lung surfactant extracts used for replacement therapy. Pediatr Res (1986) 1.37
Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP. Br J Cancer (2005) 1.36
Trityl monitoring of automated DNA synthesizer operation by conductivity: a new method of real-time analysis. Biotechniques (1993) 1.36
Effects of a cardio-selective beta-adrenergic blocking agent on the heart and coronary circulation. Cardiovasc Res (1970) 1.35
Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). Fertil Steril (2000) 1.35
Maximizing the reliability of genomic selection by optimizing the calibration set of reference individuals: comparison of methods in two diverse groups of maize inbreds (Zea mays L.). Genetics (2012) 1.34
Physical growth and developmental outcome in very low birth weight premature infants at 3 years of age. J Pediatr (1985) 1.33
Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trial. Ann Oncol (2005) 1.33
A QTL with major effect on milk yield and composition maps to bovine chromosome 14. Mamm Genome (1998) 1.32
Optimisation of circulating biomarkers of cell death for routine clinical use. Ann Oncol (2008) 1.32
Retardation of cochlear maturation and impaired hair cell function caused by deletion of all known thyroid hormone receptors. J Neurosci (2001) 1.28
Quality of care and temperament determine changes in cortisol concentrations over the day for young children in childcare. Psychoneuroendocrinology (2000) 1.28
Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system. Synapse (1995) 1.27
Chemiluminescent detection of oxidants in vascular tissue. Lucigenin but not coelenterazine enhances superoxide formation. Circ Res (1999) 1.24
Structure of general thoracic surgery in Europe. Eur J Cardiothorac Surg (2001) 1.24
The use of silastic foam dressing in the treatment of advanced hidradenitis suppurativa. Br J Surg (1980) 1.24
BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years. Br J Cancer (2012) 1.24
Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 1. Comparison of patients' ratings, observers' ratings, and objective assessments. Radiother Oncol (1992) 1.24
Prenatal exposure to alcohol: effect on infant growth and morphologic characteristics. Pediatrics (1989) 1.23
A PCR-based genetic linkage map of human chromosome 16. Genomics (1994) 1.22
Clinical effectiveness and cost-effectiveness of tests for the diagnosis and investigation of urinary tract infection in children: a systematic review and economic model. Health Technol Assess (2006) 1.22
Behavioural management in nursing and residential homes: a randomised controlled trial. Lancet (1999) 1.22
The effectiveness of intermediate care in a nursing-led in-patient unit. Int J Nurs Stud (2000) 1.20
Embryonic and early fetal development of the human neocortex. J Neurosci (2000) 1.20
Qualification of M30 and M65 ELISAs as surrogate biomarkers of cell death: long term antigen stability in cancer patient plasma. Cancer Chemother Pharmacol (2007) 1.19
Meta-analysis of QTL involved in silage quality of maize and comparison with the position of candidate genes. Theor Appl Genet (2010) 1.19
DT-diaphorase: a target for new anticancer drugs. Cancer Treat Rev (2004) 1.19
A randomised controlled trial to assess the impact of a package comprising a patient-orientated, evidence-based self-help guidebook and patient-centred consultations on disease management and satisfaction in inflammatory bowel disease. Health Technol Assess (2003) 1.18
Biochemical adaptations in the mesolimbic dopamine system in response to repeated stress. Neuropsychopharmacology (1996) 1.18
Stimulus Equivalence: Effects Of A Default-response Option On Emergence Of Untrained Stimulus Relations. J Exp Anal Behav (1998) 1.17
Distribution of the 275 kD hair cell antigen and cell surface specialisations on auditory and vestibular hair bundles in the chicken inner ear. J Comp Neurol (1992) 1.17
Variation of immunological response in methotrexate-induced pneumonitis. Rheumatology (Oxford) (2008) 1.17
Systematic review of the clinical effectiveness and cost-effectiveness of capecitabine (Xeloda) for locally advanced and/or metastatic breast cancer. Health Technol Assess (2004) 1.17
Handheld computers and paper diaries for documenting the use of factor concentrates used in haemophilia home therapy: a qualitative study. Haemophilia (2005) 1.17
Cardiac avoidance in breast radiotherapy: a comparison of simple shielding techniques with intensity-modulated radiotherapy. Radiother Oncol (2001) 1.17
What are the clinical outcome and cost-effectiveness of endoscopy undertaken by nurses when compared with doctors? A Multi-Institution Nurse Endoscopy Trial (MINuET). Health Technol Assess (2006) 1.16
Cavernous sinus invasion by pituitary adenoma: MR imaging. Radiology (2000) 1.16